Meeting
2024 ASCO Quality Care Symposium
Quality intervention to facilitate clinician-patient discussions of lung cancer biomarker testing at safety net and non safety net centers.
Presenter
Christine B. Weldon, MBA
Center for Business Models in Healthcare
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Palliative and Supportive Care
Sub Track
Application of Quality Improvement Tools
Citation
JCO Oncol Pract 20, 2024 (suppl 10; abstr 284)
DOI
10.1200/OP.2024.20.10_suppl.284
Abstract #
284
Poster Bd #
E24
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2024 ASCO Annual Meeting
Efficacy and safety of taletrectinib in patients with advanced or metastatic ROS1+ non–small cell lung cancer: The phase 2 TRUST-I study.
Speaker: Wei Li, MD
Speaker: Panel Discussion
Speaker: Panel Discussion
Videos & Slides
2022 ASCO Annual Meeting
Randomized phase 2 study evaluating efficacy and safety of inupadenant in combination with chemotherapy in adults with metastatic non–small cell lung cancer (mNSCLC) who progressed on immunotherapy.
Speaker: Mary E.R. O'Brien, MD